All News

Handelszeitung - Recolony: Mit Bakterien gegen Krebs

20-04-2023 – Ein Heilmittel gegen Krebs? Das Spin-off Recolony verspricht einen neuen Ansatz mit Darmbakterien, die bösartige Tumore bekämpfen sollen.

Philipp Busenhart, Business Development Lead of project Recolony, talks about the project in this interview with the Handelzeitung.

Read Full Article

Similar News

06-09-2023

Wyss Zurich current and alumni projects on stage at TOP100 Startup Awards 2023

Fantastic presence of current and alumni Wyss Zurich projects at TOP 100 Swiss Startup Award! ANYbotics (ANYmotion) and CUTISS (denovoSkin) again first respectively on Robotics and Biotech Scale-up...

26-09-2023

Recolony identified as one of the 15 most promising Swiss biotech startups of 2023, according to investors

Recolony has been identified as one of the 15 most promising Swiss biotech startups of 2023, according to investors.

29-02-2024

Swisspreneur Podcast - Ana Montalban-Arques: Treating Cancer with Bacteria

Ana Montalban-Arques⁠ is co-founder and CEO of ⁠Recolony⁠, a biotech startup developing a bacteria-based oral therapy to treat cancer.